In an extra analysis of the SPRINT trial, where hypertensive patients were randomised to a treatment target of 140 mm Hg or 120 mm Hg, the concerns about falling were measured on the Efficacy Scale International questionnaire at baseline, six months, one year, and annually thereafter.1
While there was an expected increase in falling concerns there was no difference between the groups randomised to 140 vs 120 mm Hg.
In the original paper there was a statistically significant increase in syncope but not in terms of injurious falls.2 With older patients it's prudent to check their blood pressures sitting and standing but at the same time remembering that older patients have the highest CVD risk so treatment is a balance of benefit against harms.